2011

2011 - Beiträge in Fachzeitschriften

Originalarbeiten (Zeitschrift)
(2011): Incidental finding of a splenic hamartoma with tumour-like extramedullary erythropoiesis. Wien Med Wochenschr. 2011; 161(15-16):394-397
(2011): Method development and validation for the analysis of a new anti-cancer infusion solution via HPLC. J Sep Sci. 2011; 34(2):135-141
(2011): Systemic arterial supply of the right lung with venous drainage to the pulmonary arterial circuit. Cardiol Young. 2011; 21(6):710-712
(2011): High extracellular levels of cefpirome in unaffected and infected lung tissue of patients. J Antimicrob Chemother. 2011; 66(1):160-164
(2011): Photodynamic therapy for esophageal carcinoma. Acta chirurgica Austriaca. Supplement.. 2011; 43(6): 355-365.
(2011): Case report: Hyperbaric oxygen in the treatment of puff adder (Bitis arietans) bite Undersea Hyperb Med. 2011; 37(6):395-398
(2011): Hyperbaric oxygenation of UW Solution positively impacts on the energy state of porcine pancreatic tissue. Acta chirurgica Austriaca. Supplement.. 2011; 43(6): 366-373.
Kurzbericht/Letter
(2011): Severe arterial air embolism following electromyography of the trapezius muscle. Acta Anaesthesiol Scand. 2011; 55(3): 369-370.
Übersichtsarbeiten
(2011): Efficacy and safety of current drug therapies for invasive aspergillosis. Pharmacology. 2011; 88(3-4): 213-224.

2011 - Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Abstracts (Zeitschrift)
(2011): Pharmacokinetic evaluation of a novel anti-cancer drug INT J CLIN PHARM. 2011; 33(2):320-320.
(2011): Metabolism of 5-hydroxymethylfurfural following the application of a novel anti-cancer infusion solution INT J CLIN PHARM. 2011; 33(2):332-333.
(2011): Neprilysin is induced by hypoxia and is a prognostic factor in non-small cell lung cancer WIEN KLIN WOCHENSCHR. 2011; 123(17-18):A24-A24.-Jahrestagung der Österreichischen Gesellschaft für Pneumologie; SEPT 8-10, 2011; Vienna, AUSTRIA.
(2011): Interdisciplinary Syncope WIEN KLIN WOCHENSCHR. 2011; 123(17-18):A10-A10.